Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2023-02-22 | Bokslutskommuniké 2022 |
| 2022-12-05 | Extra Bolagsstämma 2022 |
| 2022-07-21 | Kvartalsrapport 2022-Q2 |
| 2022-05-31 | Årsstämma 2022 |
| 2022-05-06 | Ordinarie utdelning KARO 0.00 SEK |
| 2022-02-25 | Bokslutskommuniké 2021 |
| 2021-10-28 | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | Kvartalsrapport 2021-Q2 |
| 2021-04-23 | Ordinarie utdelning KARO 0.00 SEK |
| 2021-04-21 | Kvartalsrapport 2021-Q1 |
| 2021-04-21 | Årsstämma 2021 |
| 2021-02-18 | Bokslutskommuniké 2020 |
| 2020-10-30 | Kvartalsrapport 2020-Q3 |
| 2020-07-21 | Kvartalsrapport 2020-Q2 |
| 2020-05-25 | Årsstämma 2020 |
| 2020-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2020-04-29 | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | Bokslutskommuniké 2019 |
| 2019-11-15 | Kvartalsrapport 2019-Q3 |
| 2019-09-20 | Extra Bolagsstämma 2019 |
| 2019-07-19 | Kvartalsrapport 2019-Q2 |
| 2019-05-17 | Ordinarie utdelning KARO 0.00 SEK |
| 2019-05-16 | Årsstämma 2019 |
| 2019-04-26 | Kvartalsrapport 2019-Q1 |
| 2019-02-14 | Bokslutskommuniké 2018 |
| 2018-11-01 | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | Ordinarie utdelning KARO 0.30 SEK |
| 2018-05-03 | Årsstämma 2018 |
| 2018-04-26 | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | Bokslutskommuniké 2017 |
| 2017-12-08 | Extra Bolagsstämma 2017 |
| 2017-11-02 | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | Ordinarie utdelning KARO 0.28 SEK |
| 2017-05-12 | Bonusutdelning KARO 0.22 |
| 2017-05-11 | Årsstämma 2017 |
| 2017-05-10 | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | Bokslutskommuniké 2016 |
| 2016-10-27 | Kvartalsrapport 2016-Q3 |
| 2016-07-15 | Kvartalsrapport 2016-Q2 |
| 2016-05-13 | Ordinarie utdelning KARO 0.00 SEK |
| 2016-05-12 | Kvartalsrapport 2016-Q1 |
| 2016-05-12 | Årsstämma 2016 |
| 2016-03-16 | Extra Bolagsstämma 2016 |
| 2016-02-12 | Bokslutskommuniké 2015 |
| 2015-10-29 | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | Split KARO 20:1 |
| 2015-07-10 | Kvartalsrapport 2015-Q2 |
| 2015-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2015-04-29 | Årsstämma 2015 |
| 2015-04-29 | Kvartalsrapport 2015-Q1 |
| 2015-02-13 | Bokslutskommuniké 2014 |
| 2014-10-29 | Kvartalsrapport 2014-Q3 |
| 2014-07-11 | Kvartalsrapport 2014-Q2 |
| 2014-05-09 | Ordinarie utdelning KARO 0.00 SEK |
| 2014-05-08 | Årsstämma 2014 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-03-17 | Extra Bolagsstämma 2014 |
| 2014-02-13 | Bokslutskommuniké 2013 |
| 2013-10-25 | Kvartalsrapport 2013-Q3 |
| 2013-07-12 | Kvartalsrapport 2013-Q2 |
| 2013-05-08 | Ordinarie utdelning KARO 0.00 SEK |
| 2013-05-07 | Kvartalsrapport 2013-Q1 |
| 2013-05-07 | Årsstämma 2013 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-12 | Bokslutskommuniké 2012 |
| 2013-02-12 | Analytiker möte 2013 |
| 2012-11-19 | Extra Bolagsstämma 2012 |
| 2012-10-24 | Kvartalsrapport 2012-Q3 |
| 2012-07-13 | Kvartalsrapport 2012-Q2 |
| 2012-06-12 | Årsstämma 2012 |
| 2012-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2012-04-27 | Kvartalsrapport 2012-Q1 |
| 2012-02-08 | Bokslutskommuniké 2011 |
| 2011-11-29 | 15-7 2011 |
| 2011-10-25 | Kvartalsrapport 2011-Q3 |
| 2011-07-13 | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | Ordinarie utdelning KARO 0.00 SEK |
| 2011-04-27 | Årsstämma 2011 |
| 2011-04-27 | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | Bokslutskommuniké 2010 |
| 2010-10-26 | Kvartalsrapport 2010-Q3 |
| 2010-07-13 | Kvartalsrapport 2010-Q2 |
| 2010-04-26 | Ordinarie utdelning KARO 0.00 SEK |
| 2010-04-23 | Årsstämma 2010 |
| 2010-04-22 | Kvartalsrapport 2010-Q1 |
| 2010-02-09 | Bokslutskommuniké 2009 |
| 2009-10-22 | Kvartalsrapport 2009-Q3 |
| 2009-07-14 | Kvartalsrapport 2009-Q2 |
| 2009-04-27 | Ordinarie utdelning KARO 0.00 SEK |
| 2009-04-24 | Årsstämma 1 |
| 2009-04-22 | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The Board of Directors of Karo Pharma Aktiebolag (publ) (the "Company" or "Karo Pharma") has today decided to apply for and submitted the application regarding delisting of the Company's shares from Nasdaq Stockholm as well as decided to apply for listing of the Company's shares on Nasdaq First North Growth Market (the "First North-listing").
As communicated on 15 December 2021, the Board considers that Nasdaq First North Growth Market, with its more suitable regulatory environment and lower cost of complying with continuing obligations, is a more appropriate listing venue for the Company given its strategy and shareholder base. The First North-listing is intended to be carried out in connection with the planned rights issue for repayment of the bridge loan facility provided for the financing of the acquisition of Sylphar International NV, as disclosed on 23 November 2021.
For further information, please contact:
Christoffer Lorenzen, CEO, +46 73-501 76 20, christoffer.lorenzen@karopharma.com
Jon Johnsson, CFO, +46 73-507 88 61, jon.johnsson@karopharma.com
The information was submitted for publication by the contact persons set out above, at 12:00 CET on 9 March 2022.
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 60 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm Large Cap.